Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deddo Moertl

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
European Heart Journal|July 25, 2008
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitusMartin Huelsmann, Stephanie Neuhold, Guido Strunk, et al.
Plos One|December 7, 2013
Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertensionGrzegorz Kopeć, Deddo Moertl, Sabine Steiner, et al.
European Journal of Clinical Investigation|July 14, 2018
Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failureRaphael Wurm, Lore Schrutka, Alexandra Hammer, et al.
BMC Cardiovascular Disorders|December 29, 2019
A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantationGernot Wagner, Markus Haumer, Gerhard Poelzl, et al.
Clinical Cardiology|August 15, 2020
State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapyChristoph Schukro, David Santer, Günther Prenner, et al.
Diabetes Care|July 1, 2009
Endothelial markers may link kidney function to cardiovascular events in type 2 diabetesChristina Maier, Martin Clodi, Stephanie Neuhold, et al.
Cardiovascular Diabetology|September 30, 2023
Timing of SGLT2i initiation after acute myocardial infarctionDirk von Lewinski, Ewald Kolesnik, Faisal Aziz, et al.
European Heart Journal|March 8, 2014
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysisRichard W Troughton, Christopher M Frampton, Hans-Peter Brunner-La Rocca, et al.
European Journal of Heart Failure|October 1, 2015
Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trialsHans-Peter Brunner-La Rocca, Luc Eurlings, A Mark Richards, et al.
American Heart Journal|January 19, 2022
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III studyDirk von Lewinski, Norbert J Tripolt, Harald Sourij, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
European Heart Journal|July 25, 2008
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitusMartin Huelsmann, Stephanie Neuhold, Guido Strunk, et al.
Plos One|December 7, 2013
Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertensionGrzegorz Kopeć, Deddo Moertl, Sabine Steiner, et al.
European Journal of Clinical Investigation|July 14, 2018
Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failureRaphael Wurm, Lore Schrutka, Alexandra Hammer, et al.
BMC Cardiovascular Disorders|December 29, 2019
A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantationGernot Wagner, Markus Haumer, Gerhard Poelzl, et al.
Clinical Cardiology|August 15, 2020
State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapyChristoph Schukro, David Santer, Günther Prenner, et al.
Diabetes Care|July 1, 2009
Endothelial markers may link kidney function to cardiovascular events in type 2 diabetesChristina Maier, Martin Clodi, Stephanie Neuhold, et al.
Cardiovascular Diabetology|September 30, 2023
Timing of SGLT2i initiation after acute myocardial infarctionDirk von Lewinski, Ewald Kolesnik, Faisal Aziz, et al.
European Heart Journal|March 8, 2014
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysisRichard W Troughton, Christopher M Frampton, Hans-Peter Brunner-La Rocca, et al.
European Journal of Heart Failure|October 1, 2015
Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trialsHans-Peter Brunner-La Rocca, Luc Eurlings, A Mark Richards, et al.
American Heart Journal|January 19, 2022
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III studyDirk von Lewinski, Norbert J Tripolt, Harald Sourij, et al.
Pageof 5